Woodline Partners’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.9M | Buy |
6,029,906
+5,523,718
| +1,091% | +$28.3M | 0.16% | 184 |
|
|
2025
Q1 | $693K | Buy |
506,188
+111,791
| +28% | +$153K | ﹤0.01% | 801 |
|
|
2024
Q4 | $1.22M | Buy |
+394,397
| New | +$1.22M | 0.01% | 730 |
|
|
2024
Q3 | – | Sell |
-348,091
| Closed | -$2.99M | – | 701 |
|
|
2024
Q2 | $2.99M | Buy |
+348,091
| New | +$2.99M | 0.03% | 383 |
|
|
2023
Q4 | – | Sell |
-250,000
| Closed | -$2.82M | – | 653 |
|
|
2023
Q3 | $2.82M | Sell |
250,000
-13,645
| -5% | -$154K | 0.03% | 368 |
|
|
2023
Q2 | $875K | Sell |
263,645
-97,549
| -27% | -$324K | 0.01% | 493 |
|
|
2023
Q1 | $1.43M | Sell |
361,194
-4,042
| -1% | -$16K | 0.02% | 450 |
|
|
2022
Q4 | $2.65M | Sell |
365,236
-134,859
| -27% | -$978K | 0.04% | 434 |
|
|
2022
Q3 | $1.81M | Hold |
500,095
| – | – | 0.03% | 478 |
|
|
2022
Q2 | $2.27M | Hold |
500,095
| – | – | 0.03% | 408 |
|
|
2022
Q1 | $3.79M | Buy |
500,095
+77
| +0% | +$584 | 0.06% | 278 |
|
|
2021
Q4 | $5.47M | Sell |
500,018
-22
| -0% | -$241 | 0.08% | 272 |
|
|
2021
Q3 | $6.47M | Sell |
500,040
-3,357
| -0.7% | -$43.4K | 0.11% | 221 |
|
|
2021
Q2 | $5.73M | Hold |
503,397
| – | – | 0.11% | 206 |
|
|
2021
Q1 | $5.6M | Hold |
503,397
| – | – | 0.12% | 180 |
|
|
2020
Q4 | $5.76M | Buy |
503,397
+3,397
| +0.7% | +$38.9K | 0.15% | 149 |
|
|
2020
Q3 | $5.18M | Buy |
+500,000
| New | +$5.18M | 0.17% | 126 |
|